Stockysis — AI-Powered Stock News & Sentiment Analysis

Barclays Maintains Overweight on LifeStance Health Gr, Raises Price Target to $9

Benzinga Newsdesk www.benzinga.com Positive 82.6%

Neg 0% Neu 0% Pos 82.6%

Barclays analyst Peter Warendorf maintains LifeStance Health Gr (NASDAQ:LFST) with a Overweight and raises the price target from $8 to $9.

Comments

No comments yet. Be the first!